Glycopyrrolate Injection

35.00

The dosage form available for Glycopyrrolate is Injection Solution. Wedgewood Pharmacy’s stringent quality control programs help ensure that our injection solutions meet the specifications and high standards of the pharmacy industry.

1 strength of Glycopyrrolate Injection Solution is available in 0.25 mg/ml.

The dosage form available for Glycopyrrolate is Injection Solution. Wedgewood Pharmacy’s stringent quality control programs help ensure that our injection solutions meet the specifications and high standards of the pharmacy industry.

1 strength of Glycopyrrolate Injection Solution is available in 0.25 mg/ml.

 

Glycopyrrolate Injection, USP is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. When indicated, Glycopyrrolate Injection, USP may be used intraoperatively to counteract surgically or drug-induced or vagal reflexes associated arrhythmias. Glycopyrrolate protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarizing muscle relaxants.
In Peptic Ulcer

For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.The dosage form available for Glycopyrrolate is Injection Solution. Wedgewood Pharmacy’s stringent quality control programs help ensure that our injection solutions meet the specifications and high standards of the pharmacy industry.

1 strength of Glycopyrrolate Injection Solution is available in 0.25 mg/ml.

 

USP is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the volume and free acidity of gastric secretions; and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation. When indicated, Glycopyrrolate Injection, USP may be used intraoperatively to counteract surgically or drug-induced or vagal reflexes associated arrhythmias. Glycopyrrolate protects against the peripheral muscarinic effects (e.g., bradycardia and excessive secretions) of cholinergic agents such as neostigmine and pyridostigmine given to reverse the neuromuscular blockade due to non-depolarizing muscle relaxants.
In Peptic Ulcer
For use in adults as adjunctive therapy for the treatment of peptic ulcer when rapid anticholinergic effect is desired or when oral medication is not tolerated.

Reviews

There are no reviews yet.

Be the first to review “Glycopyrrolate Injection”

Your email address will not be published. Required fields are marked *

You cannot copy content of this page